Company / Gross Margin
Nuo Therapeutics, Inc. Gross Margin History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
-51.3%
FY2017
5-year range
-54.3% / 30.8%
FY2013-FY2017
Trend
+5.5%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has fluctuated over the past 7 years, ranging from -54.3% in FY2016 to 62.9% in FY2012.
Based on SEC 10-K filings.
-51.3% in FY2017 with a 5-year CAGR of -114.3%.
Declined from 30.8% to -51.3% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -64.1pp
- 5-Year Change
- -114.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2017, gross margin increased 5.5% year-over-year.
- Peak gross margin was recorded in FY2012.
- Lowest gross margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -51.3% | +5.5% |
| FY2016 | -54.3% | -276.4% |
| FY2015 | 30.8% | +141.1% |
| FY2014 | 12.8% | -52.6% |
| FY2013 | 27.0% | -57.2% |
| FY2012 | 62.9% | +0.9% |
| FY2011 | 62.4% | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026